Cancer awareness
Cancer remains a chronic problem addressed through global health communication, including HEALTHNDEVELOPMENT magazine and media with over 20 years of experience. Our aim is to raise awareness within the global community. Learn how cancer can be prevented and treated, and how resources are being developed in collaboration with stakeholders, partners, governments, and ministries.
Prevention and treatment
Understand that cancer can be prevented and treated. We work with all stakeholders and partners, including governments and ministries, to develop resources and improve outcomes. Stay updated on the latest changes and get educated about screening and treatment options.
Comprehensive care
If affected, explore the best treatment options nationally and internationally, including chemotherapy, surgery, holistic spiritual care, and oncologists specializing in internal medicine and alternative therapies. Get screened and seek the best treatment options.
Stay informed
Get abreast with changes, be educated, get screened and if affected get best treatment options nationally and internationall including chemo , surgery , wholistic spiritaul care and oncologists specialist in internatal medicine and alternatives. For more information, contact us at [[email]] or call us at [[phonenumber]].
Dr. Thompson Ntuba Akwo Commends 2024 San Antonio Breast Cancer Symposium
Dr. Thompson Ntuba Akwo Commends 2024 San Antonio Breast Cancer Symposium
Dr. Thompson Ntuba Akwo, Editor of HealthnDevelopment Magazine, Certified Global Health Communicator, and World Health Organization–trained educator, is commending the University of Texas at San Antonio and the American Association for Cancer Research (AACR) for hosting the 2024 San Antonio Breast Cancer Symposium.
Dr. Ntuba, who continues to lead media efforts on breast cancer as a chronic disease, emphasizes that prevention through mammography, early screening, and detection remains critical. He highlights that alongside these measures, other health promotion strategies are essential in reducing the burden of breast cancer worldwide.
He notes that AACR, UT Health San Antonio, and their partners—including Novartis—are making significant strides in alleviating suffering. Novartis, in addition to providing symposium materials for attendees, is promoting Kisqali (ribociclib 200 mg tablets) as part of breast cancer management.
Dr. Ntuba Akwo, who writes and reports on cancer as part of global community awareness and education, regards the San Antonio International Symposium as one of the largest and most impactful gatherings dedicated to breast cancer. National partners such as Susan G. Komen are also participating, sharing knowledge, resources, and advancing awareness.
By Dr. Thompson Ntuba Akwo Editor, HealthnDevelopment Magazine